Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
16 sept. 2020 10h24 HE
|
Novartis International AG
First healthcare industry sustainability-linked bond (SLB) further embeds Environmental Social Governance (ESG) targets into the core of Novartis business operations SLB linked to 2025 Patient Access...
Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
01 sept. 2020 01h00 HE
|
Novartis International AG
2025 target to increase patients reached in LMICs with strategic innovative medicines by 200% and the Novartis Flagship Programs by 50% - bringing potential reach to over 23 million patients across...
LogistiCare Partners with Liberty Resources to Deliver 75 Tons of Food to Disabled Philadelphia Residents In Need
20 août 2020 11h34 HE
|
LogistiCare
Philadelphia, PA, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Philadelphia, P.A. – LogistiCare, the nation’s largest non-emergency medical transportation company, is partnering with Liberty Resources, Inc. to...
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
27 juil. 2020 03h29 HE
|
Novartis International AG
Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe Planned combined investment of more than EUR 150 million...
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
16 juil. 2020 01h15 HE
|
Novartis International AG
Portfolio of 15 generic and over-the-counter (OTC) medicines from Sandoz division addresses urgent unmet needs of low- and lower-middle-income countries to treat patients with COVID-19...
LogistiCare l Circulation innovating services to meet the changing needs amid COVID-19 pandemic
13 avr. 2020 14h00 HE
|
LogistiCare
Atlanta, April 13, 2020 (GLOBE NEWSWIRE) -- COVID-19 has brought grief and hardship to many and instilled uncertainty to all. At LogistiCare l Circulation, we are focused on supporting our...
Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo
01 avr. 2020 22h00 HE
|
Novartis International AG
Basel, April 2, 2020 – Novartis today announced the mutual agreement with Aurobindo Pharma USA Inc. to terminate the agreement to sell the Sandoz US generic oral solids and dermatology businesses to...
Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
20 mars 2020 12h00 HE
|
Novartis International AG
Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of COVID-19. Novartis Sandoz division will pursue appropriate regulatory...
Les actionnaires de Novartis approuvent toutes les résolutions proposées par le Conseil d’administration à l’Assemblée générale annuelle
28 févr. 2020 07h00 HE
|
Novartis International AG
Les actionnaires approuvent la 23e augmentation consécutive du dividende qui passe à CHF 2.95 (+4%) par action pour l’année 2019, soit un rendement de 3,5%1 et une distribution du free cash-flow...
Die Aktionäre von Novartis heissen an der Generalversammlung alle Anträge des Verwaltungsrates gut
28 févr. 2020 07h00 HE
|
Novartis International AG
Die Aktionäre bewilligen die 23. Dividendenerhöhung in Folge. Für 2019 wird die Dividende auf CHF 2.95 (+4%) je Aktie erhöht, was einer Rendite von 3.5%1 und einem Anteil von etwa 54% des freien...